402. Integrating clinical and genomic determinants of valproate-associated side effects in a Taiwanese population
VPA-induced hyperammonemia appears to be influenced by both clinical factors and genetic susceptibility, whereas liver toxicity and thrombocytopenia are primarily driven by clinical and treatment-related factors.